Evidence map›Paper›PMID 40694686›Full record

ArticleACS chemical neuroscience2025

Predicting Δ-9-Tetrahydrocannabinol-Induced Psychoactive and Cognitive Effects: A PBPK-PD Approach to Quantifying Feeling High and Reduced Alertness.

Lixuan Qian, Zhu Zhou

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lixuan QianDepartment of Chemistry, York College, City University of New York, Jamaica, New York 11451, United States.
Zhu ZhouDepartment of Chemistry, York College, City University of New York, Jamaica, New York 11451, United States.ORCID 0009-0000-2051-2239

Funding

Quantifying effects of comorbidities and genetics on cannabinoid exposure in the elderlyR16GM146679 · NIGMS · YORK COLLEGE · PI ZHOU, ZHU · 2022 to 2025
$795k
NIGMS NIH HHS R16 GM146679
6 · The paper itself

Abstract

The increasing use of cannabis for medicinal and recreational purposes highlights the need to understand its psychoactive effects. Δ-9-tetrahydrocannabinol (THC), the primary psychoactive cannabinoid, is responsible for feeling high and reduced alertness after cannabis use. This study aimed to develop and verify physiologically based pharmacokinetic-pharmacodynamic (PBPK-PD) models to quantify the effects of THC and its active metabolite, 11-hydroxy-THC, on feeling high and reduction in alertness in healthy adults. The models were developed using Simcyp, based on our previously verified THC PBPK model. A direct response model with a maximum effect (

Indexed as

CognitionDronabinolModels, BiologicalPsychotropic DrugsAdministration, InhalationAdultBrainDose-Response Relationship, DrugFemaleHumansMaleYoung Adult11-hydroxy-delta(9)-tetrahydrocannabinolDronabinolPsychotropic Drugsalertnessfeeling highPBPK−PDpharmacodynamicspsychoactiveΔ-9-tetrahydrocannabinol

Identifiers

PMID40694686
PMCPMC12333010

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.